Regulatory Roundup: Supplement GMPs, Drug Claims
This article was originally published in The Tan Sheet
Executive Summary
Dherbs strikes out in three responses; Miracle's Oringaa no miracle cure; HPLC spells trouble for Eidon; and naturally more time to comment.